🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jill Kolesar

University of Iowa

ORCID: 0000-0001-8575-4546

Biochemistry, Genetics and Molecular BiologyMedicineMathematics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810”.

Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810

Journal of Clinical Oncology(2024)10.1200/jco.23.01544

N/A

0.930DataRank · unranked

19 citations

Se Eun Kim, Wayne Harris, Sumanta K. Pal, Michael R. Pins, Jill Kolesar +13 more

Osimertinib plus necitumumab in EGFR-mutant NSCLC: Final results from an ETCTN California Cancer Consortium phase I study.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.9014

N/A

0DataRank · unranked

11 citations

Mark Krailo, Sukhmani K. Padda, Susan Groshen, Heather A. Wakelee, Karen L. Reckamp +14 more

Artesunate acts through cytochrome c to inhibit growth of pediatric AML cells

Research Square(2022)10.21203/rs.3.rs-2281276/v1

N/A

0DataRank · unranked

1 citations

Erin E. Schuler, Sally R. Ellingson, Jill Kolesar, Kristen S. Hill

Human macrophage-engineered vesicles for utilization in ovarian cancer treatment

Frontiers in Oncology(2023)10.3389/fonc.2022.1042730

N/A

0DataRank · unranked

35 citations

Namrata Anand, Abigail Anderson, J. Robert McCorkle, Khaga R. Neupane, Alexandra N. Nail +6 more

Artesunate acts through cytochrome c to inhibit growth of pediatric AML cells

Scientific Reports(2023)10.1038/s41598-023-49928-y

N/A

0DataRank · unranked

10 citations

Erin E. Schuler, Sally R. Ellingson, Jill Kolesar, Kristen S. Hill

Clinical utility of reporting research genetic predisposition testing results to Total Cancer Care participants.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.10602

N/A

0DataRank · unranked

0 citations

Shulin Zhang, Nan Lin, Justine Pickarski, Sainan Wei, Rachel W. Miller +7 more

Organelle Specific Macrophage Engineered Vesicles Differentially Reprogram Macrophage Polarization

Advanced Healthcare Materials(2024)10.1002/adhm.202401906

N/A

0DataRank · unranked

8 citations

Surya P. Aryal, Brock T. Harvey, G. San Ramon, Byeong Jae Chun, J. Robert McCorkle +4 more

Development of a Novel Protocol for Germline Testing in Pancreatic Cancer

Annals of Surgical Oncology(2024)10.1245/s10434-024-16011-3

N/A

0DataRank · unranked

5 citations

Andrew Kennedy, Angelica L. Solomon, Chelsey M. Williams, Anna M. Reagan, Emily Cassim +15 more

Inherited Germline Variants in Urinary Tract Cancer: A Multicenter Whole-Exome Sequencing Analysis and Correlation With Clinical Features and Tumor Genomics

JCO Precision Oncology(2024)10.1200/po.23.00697

N/A

0DataRank · unranked

4 citations

David A. Nix, Kristen Pauley, Samantha Greenberg, Aaron Atkinson, Kenneth M. Boucher +16 more

Clinical Utility of Molecular Tumor Board Review for Identification of Possible Germline Pathogenic Variants on Tumor Next-Generation Sequencing Reports

JCO Precision Oncology(2024)10.1200/po.24.00301

N/A

0DataRank · unranked

4 citations

James P. Collard, Ning Li, Donglin Yan, Charles S. Dietrich, Rachel W. Miller +4 more

Gender inequity and sexual harassment in the pharmacy profession: Evidence and call to action

American Journal of Health-System Pharmacy(2021)10.1093/ajhp/zxab275

N/A

0DataRank · unranked

39 citations

Jackie P. Johnston, Rebecca Smith, Andrea Sikora, Melissa L. Thompson Bastin, Jacinda C. Abdul‐Mutakabbir +16 more

Case Report: Advanced grade 2 meningioma with PBRM1 inactivation with prolonged response to immunotherapy

Frontiers in Oncology(2025)10.3389/fonc.2025.1587752

N/A

0DataRank · unranked

0 citations

Keng Hee Peh, Rachael Morgan, Harry D. Momo, David K. Orren, Stephanie Rock +5 more